Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model - Wikidata - wikimedia - TriplyDB

Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model

Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model

http://www.wikidata.org/entity/Q34755674

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1 Tumor metabolism, cancer cell transporters, and microenvironmental resistance.Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.Oncolytic viral therapy: targeting cancer stem cells Priming cancer cells for drug resistance: role of the fibroblast niche.Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture.Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.Immunochemiluminescent detection of galectin-3 in tumoral tissue from prostate.Micro-RNA149 Confers Taxane Resistance to Malignant Mesothelioma Cells via Regulation of P-glycoprotein Expression.Study of the properties of doxorubicin-resistant cells affected by acute leucosis.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking.Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.Roles of Extracellular Vesicles in Metastatic Breast Cancer.Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells Nakai Has Synergetic Effects on Doxorubicin-Induced Apoptosis

P2860

Q26745710-494B73C4-82DB-4398-AC99-C7CD4A587BE0 Q26822987-8A3075C8-0B41-4E20-AF69-E8FB63F753ED Q28547327-2BF7944E-0F59-4208-A945-DCC268DDC053 Q33584148-E5521FBF-7474-465C-B1B2-285573FB0A0F Q33688434-68F32C38-E635-4D1F-B3E7-A7F810170B68 Q34118737-4681F2F8-5AF1-4988-B120-7A8CA696B847 Q34486691-18D99B9F-A7E1-4289-9056-26205E0A843A Q34513382-2BD2695C-C5FE-4F82-8EBB-CA02F2007498 Q34956648-3944D331-5EEC-443E-8E78-891665B583B5 Q35208091-DE309BCA-EDBF-4750-95EB-BDDEB66C8298 Q35870622-128E2462-E747-4C54-A429-1F9CB9EDACF8 Q36044905-0D273D61-1596-4F79-A18D-79D9107335CE Q36110948-0E011BBA-CFB4-422D-B38B-7687828F831F Q36391073-45CCEAAE-805D-430E-8FF4-0174B59C42E4 Q36531794-E4C18569-9BA0-43B0-89D4-5FF8FD2496C9 Q36747524-708F3BD4-0330-4D9F-A399-F38D58BBA250 Q37211816-C6AB52A2-CC0A-42A9-A608-BF8649A001D6 Q37589832-42DDD4DB-A6C2-4B06-9D6F-9B5F91C3E18F Q37625534-BDF51E9F-1271-4A4C-9C66-3566E66FB43C Q37702718-54582D33-6B6A-430C-B828-5972EBF066F2 Q38212255-44CD00ED-426A-46A4-9D2C-CAFA1DA1C793 Q38232067-DD487712-CF9F-46E6-8713-8D031A0AEE81 Q38289271-5D129E8B-C2CB-42C4-981B-CCC456EE4956 Q38952569-A264F8A2-E6CB-4DC0-BA60-FB8ABB2CDF9E Q38968381-AB556E10-7C21-4EA5-9FDC-681F294ADB18 Q39302599-F9B1DB46-2A10-4792-AF18-740A781A0D66 Q41493235-6B00909E-447D-40A9-A73B-5535E0B7487E Q42580165-B7BD0604-8957-432D-8077-F766ED9663CA Q47271729-F09A72CB-3704-411B-8FE7-961DF2F73180 Q47278974-EE5A7CAA-74F0-4DD0-A54E-03AAAA93ACD4 Q48308048-A98A0BCC-8600-42F0-8391-CD6F558BE048 Q48507775-D13E33C9-817E-470A-94BF-F970F2ED1FE9 Q51581869-F4837D94-65A5-4DF1-A117-6017E16C142E Q55035055-C998E226-27CB-4C6E-A6A4-53BC103850F5 Q57167169-172556CF-6A78-4C11-B20C-57967D5067D7 Q58765247-8569F3DF-A37E-41C2-8899-D9EC9B53D568 Q58805802-F97CD73D-5FDE-4FA5-9124-05028258CDC2

P2860

Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model

http://www.wikidata.org/entity/Q34755674

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Increased expression of P-glyc ...... static 4T1 breast cancer model

@ast

Increased expression of P-glyc ...... static 4T1 breast cancer model

@en

Increased expression of P-glyc ...... static 4T1 breast cancer model

@nl

type

label

Increased expression of P-glyc ...... static 4T1 breast cancer model

@ast

Increased expression of P-glyc ...... static 4T1 breast cancer model

@en

Increased expression of P-glyc ...... static 4T1 breast cancer model

@nl

prefLabel

Increased expression of P-glyc ...... static 4T1 breast cancer model

@ast

Increased expression of P-glyc ...... static 4T1 breast cancer model

@en

Increased expression of P-glyc ...... static 4T1 breast cancer model

@nl

P1433

Q34755674-7C7034B0-3121-43FF-99B4-C98C293714EC

P1476

Q34755674-B55DD383-B913-43FD-AF0F-13D5E14A42B5

P2093

Q34755674-05C687C9-DB3E-4A0B-A004-C6C61D5FDE73

Q34755674-15833A50-4C0B-4DFF-8E9F-408E84B2505E

Q34755674-3BF60805-9A1A-40CC-8913-84FFB2F89B18

Q34755674-5324582C-D51C-4CA7-9BAC-CBA71B705B0B

Q34755674-B5A539ED-362A-4D9E-882A-1B420D38DECA

Q34755674-BD0F4777-038C-4B1A-8704-07D6DC5E0A10

Q34755674-F4C295A9-A73F-4D4A-A110-8B1DE4B82179

P2860

Q34755674-0059E5B3-2583-4F65-A121-3A5D9DAF76C2

Q34755674-005AF7DC-5946-48FF-AEA3-4E890F56CCA2

Q34755674-007E90A0-888E-4754-A568-DB14C7F045A6

Q34755674-041988CC-EEC2-4C3A-ADB4-2C3AEFD60D84

Q34755674-134A297A-3BE5-44EF-86EC-F15CA09B811C

Q34755674-189478C3-6676-462B-9417-FA7A853D675E

Q34755674-1D890C21-8DAB-4926-94F1-B1A587739F2B

Q34755674-26809C7C-7CFA-42C4-B131-D338F696C4CE

Q34755674-35AA0FD6-D8A1-442A-AE5E-85F391533348

Q34755674-39324085-0923-4F7A-82B6-30291DFCE3C7

P304

Q34755674-150AA068-D1BC-4C2B-8B98-93340D6E9008

P31

Q34755674-22BD4015-C86E-44EB-B477-DC87BFBF28EE

P356

Q34755674-6069F04A-9970-4C06-946E-EF206AB11C84

P407

Q34755674-5D5CC06F-C659-487D-808B-FAAEA8402341

P433

Q34755674-D88805B1-8A8A-42B1-AFBB-EDD00F5C223C

P478

Q34755674-B04ABB52-5FF6-40AD-B9E2-F7EDF5175A11

P577

Q34755674-61FC255E-1C91-4DBB-A1CC-F13639CCBFC1

P5875

Q34755674-26DA6276-ACA3-4E24-B6A5-4E261EBE9C53

P698

Q34755674-AA5DAD7E-4BB3-46B5-9584-E58C5AB93AB8

P932

Q34755674-1C768AB0-A68B-4829-AA78-1B3C769EF066

P356

J.AJPATH.2010.10.029

P1433

The American Journal of Pathology

P1476

Increased expression of P-glyc ...... static 4T1 breast cancer model

@en

P2093

Aliyya Haque

http://www.w3.org/2001/XMLSchema#string

Kamilah Jackson

http://www.w3.org/2001/XMLSchema#string

Krzysztof Moroz

http://www.w3.org/2001/XMLSchema#string

Lili Bao

http://www.w3.org/2001/XMLSchema#string

Rachna Jetly

http://www.w3.org/2001/XMLSchema#string

Sidhartha Hazari

http://www.w3.org/2001/XMLSchema#string

Srikanta Dash

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study

Global cancer statistics, 2002

Multidrug resistance in cancer: role of ATP-dependent transporters

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Targeting multidrug resistance in cancer

P304

838-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2010.10.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49798909

http://www.w3.org/2001/XMLSchema#string

P698

21281816

http://www.w3.org/2001/XMLSchema#string

P932

3069823

http://www.w3.org/2001/XMLSchema#string